Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04874831
Title Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors 4SC AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.